Pancreatic cancer
Conditions
Interventions
None listed
Sponsors
Chiba Cancer Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Key eligibility criteria were as follows: 1) Age >=76 years old at the registration 2) Diagnosed as invasive ductal carcinoma of pancreas by clinical or radiological findings 3) Diagnosed as cancer by the histopathological or cytological findings 4) Without history of radiotherapy or chemotherapy for pancreatic cancer 5) Out of the indication for curative surgery, or without willing of curative surgery 6) Able to receive evaluation of geriatric assessment 7) written informed consent
Exclusion criteria
Exclusion criteria: Not applicable
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of Grade 4 hematological adverse event and Grade 3-4 non-hematological adverse event | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment delay, skip and emergent admission until 3-months after the registration, progression-free survival, response rate, geriatric assessment after 3-months of treatment initiation, overall survival | — |
Countries
Japan
Contacts
Public ContactSatoshi KOBAYASHI
Kanagawa Cancer Center Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division
Outcome results
None listed